NO20012727L - 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme - Google Patents

3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme

Info

Publication number
NO20012727L
NO20012727L NO20012727A NO20012727A NO20012727L NO 20012727 L NO20012727 L NO 20012727L NO 20012727 A NO20012727 A NO 20012727A NO 20012727 A NO20012727 A NO 20012727A NO 20012727 L NO20012727 L NO 20012727L
Authority
NO
Norway
Prior art keywords
arylnitron
trisubstituted
compounds
same
pharmaceutical compositions
Prior art date
Application number
NO20012727A
Other languages
English (en)
Other versions
NO20012727D0 (no
Inventor
L David Waterbury
Allan Lee Wilcox
John Michael Carney
Farah Mavandadi
Albert Danielzadeh
Original Assignee
Centaur Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centaur Pharmaceuticals Inc filed Critical Centaur Pharmaceuticals Inc
Publication of NO20012727D0 publication Critical patent/NO20012727D0/no
Publication of NO20012727L publication Critical patent/NO20012727L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20012727A 1998-12-02 2001-06-01 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme NO20012727L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11054198P 1998-12-02 1998-12-02
PCT/US1999/028479 WO2000032567A1 (en) 1998-12-02 1999-12-01 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same

Publications (2)

Publication Number Publication Date
NO20012727D0 NO20012727D0 (no) 2001-06-01
NO20012727L true NO20012727L (no) 2001-07-26

Family

ID=22333591

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012727A NO20012727L (no) 1998-12-02 2001-06-01 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme

Country Status (21)

Country Link
US (1) US6342523B1 (no)
EP (1) EP1135367A1 (no)
JP (1) JP2002531435A (no)
KR (1) KR20010087407A (no)
CN (1) CN1334800A (no)
AU (1) AU773343B2 (no)
BR (1) BR9915886A (no)
CA (1) CA2353402A1 (no)
CZ (1) CZ20011830A3 (no)
EA (1) EA004931B1 (no)
HK (1) HK1044147A1 (no)
HU (1) HUP0104576A3 (no)
IL (1) IL143506A0 (no)
IS (1) IS5958A (no)
NO (1) NO20012727L (no)
NZ (1) NZ512032A (no)
PL (1) PL349916A1 (no)
SK (1) SK7502001A3 (no)
UA (1) UA66401C2 (no)
WO (1) WO2000032567A1 (no)
ZA (1) ZA200104378B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050107366A1 (en) * 1991-06-18 2005-05-19 Carney John M. Spin trapping pharmaceutical compositions and methods for use thereof
US6730700B2 (en) 1998-12-02 2004-05-04 Renovis, Inc. 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
AU2002253857A1 (en) * 2001-01-08 2002-09-04 Centaur Pharmaceuticals, Inc. Use of aryl nitrone compounds in methods for treating neuropathic pain
US20030045461A1 (en) * 2001-09-06 2003-03-06 Jen-Chang Hsia Composition and methods of esterified nitroxides gated with carboxylic acids
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
TW200404069A (en) * 2002-06-28 2004-03-16 Upjohn Co Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
US7115666B2 (en) * 2002-10-15 2006-10-03 Renovis, Inc. Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
US20050059638A1 (en) * 2003-08-04 2005-03-17 Kelly Michael G. Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
WO2005087214A1 (en) * 2004-03-09 2005-09-22 Renovis, Inc. Methods for treating multiple sclerosis and pharmaceutical compositions therefor
CA2715326C (en) 2008-02-12 2017-06-13 Tosk, Incorporated Toxicity-reducing nitrone adjuvants for doxorubicin and use of the same
CN101468970B (zh) 2008-04-25 2011-05-11 暨南大学 一种硝酮类化合物及其制备方法和在制药中的应用
CN102311396B (zh) * 2010-07-05 2015-01-07 暨南大学 一种吡嗪类衍生物和其制备方法及在制药中的应用
US9156862B2 (en) 2011-11-01 2015-10-13 The Florida International University Board Of Trustees Silylated azulenyl nitrone spin traps as chromotropic superoxide detectors
CN104803880B (zh) * 2014-01-23 2017-11-21 广州喜鹊医药有限公司 一种具有神经保护作用的化合物及其制备方法和应用
CN109438288B (zh) * 2018-10-22 2021-05-07 河南中医药大学 一种n-硝酮取代芳香酰胺衍生物及其制备方法
US20240165148A1 (en) 2021-03-15 2024-05-23 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224340A (en) 1977-10-06 1980-09-23 William H. Rorer, Inc. Anti-inflammatory compositions containing α-phenyl-N-phenylnitrone compounds
GB2137619A (en) 1983-03-30 1984-10-10 Gerald Scott Nitrone compounds and stabilised rubber compositions containing them
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
FI93954C (fi) 1988-11-29 1995-06-26 Warner Lambert Co Menetelmä lääkeaineina käyttökelpoisten 3,5-di-tert-butyyli-4-hydroksifenyylisubstituoitujen 1,2,4- ja 1,3,4-tiadiatsolien sekä oksadiatsolien ja triatsolien valmistamiseksi
US5036097A (en) 1989-10-17 1991-07-30 Oklahoma Medical Research Foundation Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration
ATE110565T1 (de) 1989-10-17 1994-09-15 Oklahoma Med Res Found Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten.
US5025032A (en) 1989-10-17 1991-06-18 Oklahoma Medical Research Foundation Phenyl butyl nitrone compositions and methods for treatment of oxidative tissue damage
US5622994A (en) 1989-10-17 1997-04-22 Oklahoma Medical Research Foundation Spin trapping pharmaceutical compositions and methods for use thereof
US5143928A (en) 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
US6002001A (en) 1991-06-18 1999-12-14 Oklahoma Medical Research Foundation Spin trapping pharmaceutical compositions and methods for use thereof
US5270319A (en) 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5215986A (en) 1992-06-01 1993-06-01 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene oxaza heterocycles
US5840746A (en) 1993-06-24 1998-11-24 Merck Frosst Canada, Inc. Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
US5455272A (en) 1993-10-22 1995-10-03 Oklahoma Medical Research Foundation Spin trap nitronyl hindered phenols
US5488145A (en) 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
IL126725A0 (en) * 1996-04-23 1999-08-17 Centaur Pharmaceuticals Inc Compositions comprising a nitrone compound for use in treating ocular inflammation
EP1021430A1 (en) 1996-07-19 2000-07-26 Centaur Pharmaceuticals, Inc. Furan nitrone compounds
TW429241B (en) 1996-09-26 2001-04-11 Sumitomo Pharma Nitrone derivatives
US5994396A (en) 1997-08-18 1999-11-30 Centaur Pharmaceuticals, Inc. Furansulfonic acid derivatives and pharmaceutical compositions containing the same
US6046232A (en) 1997-10-17 2000-04-04 Centaur Pharmaceuticals, Inc. α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
US6015831A (en) 1998-01-16 2000-01-18 Centaur Pharmaceuticals, Inc. Thiophene nitrone compounds
CN1291980A (zh) 1998-01-16 2001-04-18 桑道药品有限公司 硫醚呋喃硝酮化合物
AU3000999A (en) 1998-03-13 1999-09-27 Renovis, Inc. Inhibition of angiogenesis
DK1077694T3 (da) 1998-05-19 2004-11-22 Renovis Inc Arylnitron-terapeutika til behandling af inflammatorisk tarmsygdom

Also Published As

Publication number Publication date
PL349916A1 (en) 2002-10-07
AU773343B2 (en) 2004-05-20
BR9915886A (pt) 2001-08-21
US6342523B1 (en) 2002-01-29
KR20010087407A (ko) 2001-09-15
IS5958A (is) 2001-05-31
HUP0104576A2 (hu) 2002-05-29
UA66401C2 (en) 2004-05-17
JP2002531435A (ja) 2002-09-24
AU1929800A (en) 2000-06-19
HUP0104576A3 (en) 2002-11-28
CN1334800A (zh) 2002-02-06
WO2000032567A1 (en) 2000-06-08
IL143506A0 (en) 2002-04-21
ZA200104378B (en) 2002-08-28
SK7502001A3 (en) 2002-02-05
EA200100607A1 (ru) 2001-12-24
HK1044147A1 (zh) 2002-10-11
NO20012727D0 (no) 2001-06-01
CZ20011830A3 (cs) 2001-10-17
CA2353402A1 (en) 2000-06-08
NZ512032A (en) 2004-02-27
EP1135367A1 (en) 2001-09-26
EA004931B1 (ru) 2004-10-28

Similar Documents

Publication Publication Date Title
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
PT946100E (pt) Composicoes herbicidas contendo n-¬(4,6-dimetoxipirimidin-2-il)aminocarbonil|-5-metilsulfonamidometil-2-alcoxicarbonilbenzenossulfonamidas
TR199501447A2 (tr) Oral bilesimler.
ID27415A (id) Komposisi farmaseutik
EA199900373A3 (ru) Фармацевтические композиции
HUP0103256A3 (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
HUP0102483A3 (en) Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol
HUP0102453A3 (en) Adenosine derivatives, their use and pharmaceutical compositions containing the compounds
NO20001914D0 (no) <alfa>-Aryl-N-alkylnitroner og farmasøytiske blandinger som inneholder slike
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
IL138725A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
NO20012727D0 (no) 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme
ITRM940002A0 (it) Composizione orale.
HUP0105075A3 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives, their use and pharmaceutical compositions containing them
EE200000447A (et) 1,3,4-oksadiasolooni derivaadid
NO960272L (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
DK0811593T3 (da) 1,4-diaryl-2-flour-2-buten som insektcider og acaricider
IL143439A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
ZA991232B (en) New compound and pharmaceutical compositions thereof.
TR199901017A3 (tr) Böcek ilaci terkibi.
ATE234839T1 (de) 4,5-azolo-oxindole

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application